Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

NCT01004185 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Pediatric enrollment very slow.

Conditions

Ulcerative Colitis

Interventions

DRUG: Asacol 400 mg
DRUG: Asacol 400 mg

Sponsor

Warner Chilcott